• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新阴性症状评估工具的初步开发和验证:临床评估访谈阴性症状量表(CAINS)。

Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).

机构信息

University of Maryland, College Park, MD 20742-4411, United States.

出版信息

Schizophr Res. 2010 Dec;124(1-3):36-42. doi: 10.1016/j.schres.2010.08.039. Epub 2010 Sep 24.

DOI:10.1016/j.schres.2010.08.039
PMID:20869848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2981616/
Abstract

As part of an ongoing scale development process, this study provides an initial examination of the psychometric properties and validity of a new interview-based negative symptom instrument, the Clinical Assessment Interview for Negative Symptoms (CAINS), in outpatients with schizophrenia or schizoaffective disorder (N = 37). The scale was designed to address limitations of existing measures and to comprehensively assess five consensus-based negative symptoms: asociality, avolition, anhedonia (consummatory and anticipatory), affective flattening, and alogia. Results indicated satisfactory internal consistency reliability for the total CAINS scale score and promising inter-rater agreement, with clear areas identified in need of improvement. Convergent validity was evident in general agreement between the CAINS and alternative negative symptom measures. Further, CAINS subscales significantly correlated with relevant self-report emotional experience measures as well as with social functioning. Discriminant validity of the CAINS was strongly supported by its small, non-significant relations with positive symptoms, general psychiatric symptoms, and depression. These preliminary data on an early beta-version of the CAINS provide initial support for this new assessment approach to negative symptoms and suggest directions for further scale development.

摘要

作为正在进行的量表开发过程的一部分,本研究初步考察了一种新的基于访谈的阴性症状量表——临床评估访谈阴性症状量表(CAINS)在精神分裂症或分裂情感障碍门诊患者中的心理测量特性和效度(N=37)。该量表旨在解决现有测量方法的局限性,并全面评估基于共识的五种阴性症状:社交退缩、意志减退、快感缺失(体验性和预期性)、情感迟钝和寡语。结果表明,CAINS 总分的内部一致性信度令人满意,评分者间一致性有一定提高空间,还明确了需要改进的领域。CAINS 与其他阴性症状测量方法之间的一致性较好,表明其具有良好的聚合效度。此外,CAINS 分量表与相关的自我报告情感体验测量以及社会功能显著相关。CAINS 的区分效度也得到了很好的支持,其与阳性症状、一般精神病症状和抑郁之间的关系较小且不显著。CAINS 的这些初步数据是其早期 beta 版本的初步支持,为阴性症状的这种新评估方法提供了初步支持,并为进一步的量表开发提供了方向。

相似文献

1
Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).新阴性症状评估工具的初步开发和验证:临床评估访谈阴性症状量表(CAINS)。
Schizophr Res. 2010 Dec;124(1-3):36-42. doi: 10.1016/j.schres.2010.08.039. Epub 2010 Sep 24.
2
The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.阴性症状临床评估访谈(CAINS):最终的开发和验证。
Am J Psychiatry. 2013 Feb;170(2):165-72. doi: 10.1176/appi.ajp.2012.12010109.
3
Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).验证德语版的阴性症状临床评估访谈(CAINS)。
Psychiatry Res. 2014 Dec 15;220(1-2):659-63. doi: 10.1016/j.psychres.2014.07.070. Epub 2014 Aug 1.
4
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).《阴性症状临床评估访谈(CAINS)的编制与心理测量学验证》。
Schizophr Res. 2011 Nov;132(2-3):140-5. doi: 10.1016/j.schres.2011.06.030. Epub 2011 Jul 27.
5
Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.阴性症状筛查:来自阴性症状临床评估访谈自评版的初步结果。
Schizophr Res. 2012 Mar;135(1-3):139-43. doi: 10.1016/j.schres.2011.12.007. Epub 2012 Jan 21.
6
Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.在临床实践中精神分裂症管理多中心全国性研究(MOSAIC)中检验阴性症状临床评估访谈的信度和效度。
Schizophr Res. 2017 Jul;185:137-143. doi: 10.1016/j.schres.2017.01.011. Epub 2017 Jan 11.
7
A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.阴性症状临床评估访谈与简明阴性症状量表的心理测量学比较
Schizophr Bull. 2016 Nov;42(6):1384-1394. doi: 10.1093/schbul/sbw046. Epub 2016 May 12.
8
Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.评估精神分裂症的阴性症状:新加坡阴性症状临床评估访谈的有效性。
Schizophr Res. 2019 Apr;206:177-182. doi: 10.1016/j.schres.2018.11.029. Epub 2018 Dec 14.
9
Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).阴性症状临床评估量表(CAINS)西班牙语版本的验证
Schizophr Res. 2015 Aug;166(1-3):104-9. doi: 10.1016/j.schres.2015.06.006. Epub 2015 Jun 23.
10
Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.阴性症状评定量表-自评版(NSI-SR):初步编制与验证。
Schizophr Res. 2023 Jun;256:79-87. doi: 10.1016/j.schres.2023.04.015. Epub 2023 May 10.

引用本文的文献

1
Relationship between negative symptoms, cognitive function and social function in schizophrenia: new insight from a network analysis.精神分裂症的阴性症状、认知功能与社会功能之间的关系:基于网络分析的新见解
Front Psychiatry. 2025 Jun 26;16:1623147. doi: 10.3389/fpsyt.2025.1623147. eCollection 2025.
2
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).COSMIN对阳性和阴性症状量表(PANSS)测量属性的系统评价与Meta分析。
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
3
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping.精神分裂症阴性症状评估:从共识会议衍生量表到远程数字表型分析
Brain Sci. 2025 Jan 17;15(1):83. doi: 10.3390/brainsci15010083.
4
Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape.精神分裂症的阴性症状:研究评估以及当前和未来治疗前景的最新进展
CNS Drugs. 2025 Mar;39(3):243-262. doi: 10.1007/s40263-024-01151-7. Epub 2025 Jan 12.
5
Clinician-Reported Negative Symptom Scales: A Systematic Review of Measurement Properties.临床医生报告的阴性症状量表:测量属性的系统评价
Schizophr Bull. 2024 Dec 20;51(1):3-16. doi: 10.1093/schbul/sbae168.
6
Using machine learning to understand social isolation and loneliness in schizophrenia, bipolar disorder, and the community.利用机器学习理解精神分裂症、双相情感障碍及社区中的社会隔离与孤独感。
Schizophrenia (Heidelb). 2024 Oct 5;10(1):88. doi: 10.1038/s41537-024-00511-y.
7
Cortical and Subcortical Structural Morphometric Profiles in Individuals with Nonaffective and Affective Early Illness Psychosis.非情感性和情感性早期疾病性精神病患者的皮质和皮质下结构形态测量特征
Schizophr Bull Open. 2022 Apr 26;3(1):sgac028. doi: 10.1093/schizbullopen/sgac028. eCollection 2022 Jan.
8
Using computer vision of facial expressions to assess symptom domains and treatment response in antipsychotic-naïve patients with first-episode psychosis.利用面部表情的计算机视觉评估初发精神病且未服用过抗精神病药物患者的症状领域及治疗反应。
Acta Psychiatr Scand. 2025 Mar;151(3):270-279. doi: 10.1111/acps.13743. Epub 2024 Aug 12.
9
An Introduction to the Human Connectome Project for Early Psychosis.早期精神病的人类连接组计划介绍
Schizophr Bull. 2025 May 8;51(3):658-671. doi: 10.1093/schbul/sbae123.
10
Social cognition and social motivation in schizophrenia and bipolar disorder: are impairments linked to the disorder or to being socially isolated?精神分裂症和双相情感障碍中的社会认知和社会动机:损伤是与疾病本身有关,还是与社会隔离有关?
Psychol Med. 2024 Jul;54(9):2015-2023. doi: 10.1017/S0033291724000102. Epub 2024 Feb 5.

本文引用的文献

1
Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.迈向下一代阴性症状评估:推进精神分裂症阴性症状评估的合作。
Schizophr Bull. 2011 Mar;37(2):291-9. doi: 10.1093/schbul/sbq104. Epub 2010 Sep 22.
2
A meta-analysis of controlled research on social skills training for schizophrenia.精神分裂症社交技能训练对照研究的荟萃分析。
J Consult Clin Psychol. 2008 Jun;76(3):491-504. doi: 10.1037/0022-006X.76.3.491.
3
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.第二代抗精神病药物的效果如何?安慰剂对照试验的荟萃分析。
Mol Psychiatry. 2009 Apr;14(4):429-47. doi: 10.1038/sj.mp.4002136. Epub 2008 Jan 8.
4
Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor.精神分裂症的认知行为疗法:效应量、临床模型及方法学严谨性
Schizophr Bull. 2008 May;34(3):523-37. doi: 10.1093/schbul/sbm114. Epub 2007 Oct 25.
5
Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure.精神分裂症中的快感缺失:预期性愉悦与满足性愉悦之间的区别。
Schizophr Res. 2007 Jul;93(1-3):253-60. doi: 10.1016/j.schres.2007.03.008. Epub 2007 May 9.
6
ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004.欧洲神经精神药理学会共识会议。精神分裂症的阴性、抑郁和认知症状。英国国家卫生与临床优化研究所,2004年3月
Eur Neuropsychopharmacol. 2007 Jan;17(1):70-7. doi: 10.1016/j.euroneuro.2006.05.004. Epub 2006 Jul 13.
7
The NIMH-MATRICS consensus statement on negative symptoms.美国国立精神卫生研究所-测量与治疗研究改善精神分裂症认知功能共识声明:阴性症状部分
Schizophr Bull. 2006 Apr;32(2):214-9. doi: 10.1093/schbul/sbj053. Epub 2006 Feb 15.
8
The structure of negative symptoms within schizophrenia: implications for assessment.精神分裂症中阴性症状的结构:对评估的启示
Schizophr Bull. 2006 Apr;32(2):238-45. doi: 10.1093/schbul/sbj013. Epub 2005 Oct 27.
9
Anhedonia in schizophrenia: a review of assessment strategies.精神分裂症中的快感缺失:评估策略综述
Schizophr Bull. 2006 Apr;32(2):259-73. doi: 10.1093/schbul/sbj009. Epub 2005 Oct 12.
10
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.为精神分裂症临床试验建立共识性认知成套测验:美国国立精神卫生研究所-精神分裂症认知功能评估委员会会议选定认知领域及测试标准
Biol Psychiatry. 2004 Sep 1;56(5):301-7. doi: 10.1016/j.biopsych.2004.06.023.